Acoustic Neuroma: Viewpoint—Surgery
Fig. 24.1 (a) A 5 cm acoustic neuroma prior to resection. The patient presented with tinnitus, hearing loss, and signs of brainstem compression. (b) Postoperative image after a retrosigmoid craniotomy….
Epilepsy: Viewpoint—Medical
First generation Second generation Third generation Carbamazepine Felbamatea Clobazam Phenytoinb,c Gabapentin Ezogabinea Phenobarbitalb Lamotrigine Lacosamideb,c Primidone Levetiracetamb,c Perampanel Valproateb,c Oxcarbazepine Pregabalinb Tiagabine Rufinamide Topiramate Vigabatrina Zonisamide aUse limited by significant…
Stereotactic Radiosurgery for Movement Disorders
Author (year) n Disease Targeting Use of plug Unilateral or bilateral treatment Prescription dose (maximum dose, Gy) Follow-up Effects Complication rate (%) Complication Pan (1996) [8] 8 Parkinson’s disease Based…
Spinal Tumors and Radiosurgery
Author Patients (lesions) Histology Total dose (range)/No. of fractions (range) Spinal cord dose Follow-up (months) Local control Myelopathy Moss et al. [3] 16 (16) Hemangioblastoma 21 Gy (20–25 Gy)/2 (1–3)…
The History of Stereotactic Radiosurgery
Fig. 1.1 Henry T. Wycis holding Spiegel–Wycis stereotactic frame with Horsley-Clarke frame on the table. From Textbook of Stereotactic and Functional Neurosurgery. Lozano, Andres M.; Gildenberg, Philip L.; Tasker, Ronald…
Patient Care and Socio-Economic Issues
Related posts: Imaging Techniques in Stereotactic Radiosurgery Trigeminal Neuralgia: Viewpoint—Medical Management Stereotactic Radiosurgery for Movement Disorders Building a Radiosurgery Practice Arteriovenous Malformations: Viewpoint—Surgery Arteriovenous Malformation Radiosurgery
Ocular and Orbital Tumors: Viewpoint-Fractionated Radiation
Author Year Reference n Technique Total dose (Gy) Dose per fraction (Gy) Visual outcome Tumor outcome Re-progression (%) Radiation-induced toxicities Improved (%) Stable (%) Worse (%) Control (%) Progression (%)…
Malignant Glioma: Viewpoint—Chemotherapy
Mechanism of action Toxicity Carmustine (BCNU) Chlorethylating agent Myelosuppression Nausea/vomiting Pulmonary fibrosis Lomustine (CCNU) Chlorethylating agent Myelosuppression Nausea/vomiting (Pulmonary fibrosis) Nimustine (ACNU) Chlorethylating agent Myelosuppression Nausea/vomiting Thrombocytopenia Fotemustine Chlorethylating…
Movement Disorders: Viewpoint—Medical Therapy
and Sara S. Dhanani2 (1) Department of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA (2) Department of Neurology, Banner Sunreach Research Institute, Sun City, AZ, USA…
Trigeminal Neuralgia: Viewpoint—Medical Management
25. Court JE, Kase CS. Treatment of Tic Douloureux with a new anticonvulsant (Clonazepam). J Neurol Neurosurg Psychiatry. 1976;39:297–9.PubMedCentralPubMedCrossRef Related posts: Imaging Techniques in Stereotactic Radiosurgery Patient Care and Socio-Economic…
